VeriMom¿Debo evitar retinoyl tripeptide-35 durante el embarazo? | VeriMom
Ingredient is described in patents/databases as the product of retinoic acid and tripeptide-35 (i.e. contains a retinoid moiety), which creates a structural alert for retinoid-associated reproductive risk; no harmonised CLP classification, no EU Annex II/III listing, and no peer‑reviewed reproductive/developmental studies for this specific compound were located. Evidence: ingredient descriptions/patents identify it as retinoyl (retinoic acid) conjugate. Sources searched found no SCCS/CIR opinions or PubMed toxicology studies.
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es retinoyl tripeptide-35 seguro durante el embarazo?
- Ingredient is described in patents/databases as the product of retinoic acid and tripeptide-35 (i.e. contains a retinoid moiety), which creates a structural alert for retinoid-associated reproductive risk; no harmonised CLP classification, no EU Annex II/III listing, and no peer‑reviewed reproductive/developmental studies for this specific compound were located. Evidence: ingredient descriptions/patents identify it as retinoyl (retinoic acid) conjugate. Sources searched found no SCCS/CIR opinions or PubMed toxicology studies.
- ¿Es retinoyl tripeptide-35 seguro durante la lactancia?
- Same rationale as pregnancy: presence of a retinoid moiety raises class-based concern. No data were found on milk transfer or lactation-specific studies for this compound. No regulatory restriction (Annex II/III) or harmonised H‑codes for this specific ingredient were found.
- ¿Es retinoyl tripeptide-35 seguro para la piel del bebé?
- No infant-specific studies located. Because adult topical absorption is plausible (retinoid moiety, low molecular-weight peptide conjugates sometimes penetrate), exposure for infants (0–3 yr) is increased by +1 per your rules. No evidence was found that the ingredient is non‑absorbable or that it does not release retinoic acid in vivo.
- ¿Cómo puntúa VeriMom a retinoyl tripeptide-35?
- VeriMom puntúa retinoyl tripeptide-35 en 13/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a retinoyl tripeptide-35 en el embarazo?
- Consulta nuestra lista de alternativas seguras a retinoyl tripeptide-35 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.